1 documents found
Information × Registration Number 0212U008828, 0110U001207 , R & D reports Title To study causes and freguency of multidrug resistent tuberculosis in patient with newly detected, chronics cases and relapses of disease and to develop the efficient of therapy schemes popup.stage_title Head Cherenko Svitlana Olexandrivna, Registration Date 04-01-2013 Organization Institute of tuberculosis and pulmonology named by F. G. Yanovsky popup.description2 Object: 487 patients with multidrug resistant tuberculosis (MDR TB) of the lungs. Objective: to improve the treatment results of patients with MDR TB by developing optimal combinations and the number of anti-TB drugs in the regimens of chemotherapy (CT), and set the length of the intensive and continuation phases of CT. Methods: clinical, radiological, laboratory, microbiological. Among patients with advanced MDR TB extensively drug-resistant tuberculosis (XDR TB) occurs in 22,4 % of cases, mainly in patients treated with anti-TB drugs of I-II line. Risk of developing XDR TB have the patients, who were treated in the past with anti-TB drugs of I-II line, with bilateral infiltrative focal lesions in the lungs and large cavities, anti-TB drugs cancellation due to poor tolerability. The effectiveness of treatment is reduced in XDR, low adherernce to treatment, case of presence of 2 and more cavities of various sizes, the extensive and symptomatic lung disease, the use in the past regimes with anti-TB drugs of I-II line; F drug-resistance of MBT; use at the initial phase of chemotherapy 3 anti-TB drugs which have retained sensitivity . Developed individual chemotherapy regimens requiring appointment of 1-3 anti-TB drugs with weak activity to which MBT is resistant, in addition to 3-5 anti-TB drugs to which MBT is susceptible. It was established efficacy and tolerability of the developed regimens for XDR, which allows to achieve sputum conversion in 52,9 % patients and improve the treatment results on 12,9 %. Sphere of application - phthisiology. Product Description popup.authors Бялик Йосип Борисович Литвиненко Наталя Анатоліївна. Погребна Марина Віталіївна Сенько Юлія Олександрівна Черенько Світлана Олександрівна popup.nrat_date 2020-04-02 Close
R & D report
Head: Cherenko Svitlana Olexandrivna. To study causes and freguency of multidrug resistent tuberculosis in patient with newly detected, chronics cases and relapses of disease and to develop the efficient of therapy schemes. (popup.stage: ). Institute of tuberculosis and pulmonology named by F. G. Yanovsky. № 0212U008828
1 documents found

Updated: 2026-03-27